NCT03990688View on ClinicalTrials.gov

A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 3, 2019

Primary Completion Date

September 9, 2020

Study Completion Date

September 21, 2020

Conditions
Healthy
Interventions
DRUG

AK3280

Active Substance: AK3280, Pharmaceutical Form: Tablet, Route of Administration: Oral

DRUG

Placebo

Active Substance: Placebo, Pharmaceutical Form: Tablet, Route of Administration: Oral

Trial Locations (1)

Unknown

CTC Clinical Trial Consultants AB, Uppsala

All Listed Sponsors
lead

Shanghai Ark Biopharmaceutical Co., Ltd.

INDUSTRY

NCT03990688 - A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects | Biotech Hunter | Biotech Hunter